At a Glance
| 25I-NBOH | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Routes | sublingual | oral |
| Effects | 58 documented | 51 documented |
Dosage
Only in 25I-NBOH
sublingual
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 200–500 µg |
| Common | 500–900 µg |
| Strong | 900–1400 µg |
Only in 1cP-AL-LAD
oral
| Level | Dose |
|---|---|
| Threshold | 20 µg |
| Light | 50–100 µg |
| Common | 100–225 µg |
| Strong | 225–350 µg |
| Heavy |
Duration
Only in 25I-NBOH
sublingual
Afterglow
Onset: 15 min – 1 hrsCome Up: 30 min – 1.5 hrsPeak: 2 hrs – 3.5 hrsOffset: 1.5 hrs – 2.5 hrsAfterglow: 72 hrs – 288 hrs
Total: 5 hrs – 8 hrs
Only in 1cP-AL-LAD
oral
Peak
Effects
Safety
Interaction: 25I-NBOH + 1cP-AL-LAD
No direct interaction data available between these substances. This does not mean the combination is safe.
25I-NBOH — Dangerous Interactions
No dangerous interactions recorded.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 25I-NBOH and 1cP-AL-LAD?
25I-NBOH is classified as a Psychedelic (Substituted phenethylamines) while 1cP-AL-LAD is classified as a Psychedelic (Lysergamides). They share 43 effects in common, with 15 effects unique to 25I-NBOH and 8 unique to 1cP-AL-LAD.
Is it safe to combine 25I-NBOH and 1cP-AL-LAD?
There is no direct interaction data available for combining 25I-NBOH and 1cP-AL-LAD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 25I-NBOH or 1cP-AL-LAD?
25I-NBOH and 1cP-AL-LAD are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.